Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical TrialsBy: Renub Research Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018. Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. A. Global – Cancer Testing Market and New Cases (Chapter 2) B. Global – Cancer Testing Market Share & Forecast (Chapter 3) C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4) D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5) E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6) F. Geographic Region – Number of New Cancer Cases (Chapter 7) G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8) Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4) • Prostate Specific Antigen (PSA) Test Market & Forecast • Fecal Occult Blood Test Market & Forecast • Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast • Human Papilloma Virus (HPV) Test Market & Forecast • Bladder Test Market & Forecast • Serum Based Cancer Markers Market & Forecast • Pharmacognostic Histology Market & Forecast • Flow Cytometry Market & Forecast • Other Test Market & Forecast Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5) • Bladder Cancer Test Market & Forecast • Breast Cancer Test Market & Forecast • Cervical Cancer Test Market & Forecast • Colorectal (Colon) Cancer Test Market & Forecast • Ovarian Cancer Test Market & Forecast • Prostate Cancer Test Market & Forecast • Liver Cancer Test Market & Forecast • Flow Cytometry Market & Forecast • Other Organ Specific Cancer Test Market & Forecast Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6) 1Abbott 11Genomic Health Inc 2Radient Pharmaceuticals 12QIAGEN Marseille (Earlier Ipsogen) 3BD Diagnostics 13Myriad Genetics, Inc 4Beckman Coulter, Inc. 14Panacea Pharmaceuticals, Inc. 5BioCurex 15Qiagen 6bioMerieux 16Siemens Heathcare Diagnostics 7Cepheid 17Roche 8CytoCore Inc. 18Ventana Medical Systems 9DiagnoCure, Inc 19Trovagene Inc 10Gen-Probe, Inc. 20Vermillion, Inc Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7) 1. Africa 2. Americas 3. Asia 4. Europe 5. Oceania Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8) 1Bladder Cancer 15Myeloma 2Brain Cancer 16Nasopharynx 3Breast Cancer 17Non-Hodgkin Lymphoma 4Cervix Cancer 18Oesophagus 5Colorectal Cancer 19Oral Cavity 6Corpus Cancer 20Other Pharynx 7Hodgkin’s Lymphoma 21Ovary Cancer 8Kaposi Sarcoma 22Pancreas Cancer 9Kidney Cancer 23Prostate Cancer 10Larynx Cancer 24Stomach Cancer 11Leukaemia 25Testis Cancer 12Liver Cancer 26Thyroid Cancer 13Lung Cancer 27Other Sites 14Melanoma Cancer Site - Clinical Trials (Chapter 8) 1. Bladder Cancer 2. Cervical Cancer 3. Colorectal Cancer 4. Liver Cancer 5. Ovarian Cancer 6. Prostate Cancer Data Sources This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Renub Research team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases. Click here to view the report details: http://www.renub.com/ For more information visit: http://www.renub.com/ Contact Us Andy Hill Sr. Manager - Publisher Relation Sales & Marketing Div Renub Research Email: info@renub.com Phone: +1-678- Web: http://www.renub.com/ End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number